Relapsed Acute Lymphoblastic Leukemia (ALL)

DBCOND0069491Bone Marrow DiseasesHematologic Neoplasms

Relapsed Acute Lymphoblastic Leukemia (ALL) is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
relapsed ALL · Relapsed Acute Lymphoblastic Leukemia · Acute Lymphoblastic Leukemia, in Relapse · acute, relapsed Lymphoblastic Leukemia
Classified under
Indicated drugs

Resolves to

Vocabularies
ICD-10C91.02UMLSC2854088

What you can answer from here — as of November 01, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
77Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Relapsed Acute Lymphoblastic Leukemia (ALL) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In